Investing Profile

Barbara Schilberg

InvestorFormer CEOVCAdvisor

Managing Director at BioAdvance

Photo of Barbara Schilberg, Managing Director at BioAdvance

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
BioAdvance Managing Director
$1.5M - $5.0M
$3.3M
2
CompanyStageDateRound SizeTotal Raised
Pillo Health
Seed RoundFeb 2017$1.5M
$1.5M
Keriton
Seed RoundFeb 2017$1M
$1M
Co-investors: Shahram Hejazi (BioAdvance)